Research and innovation to reduce the burden of antibiotic resistance: strengthening the European action

In the framework of the French Presidency of the Council of the European Union (PFUE 2022), and under the high patronage of the Ministry of Higher Education, Research and Innovation (MESRI), Inserm and Institut Pasteur are organising a scientific symposium on antibiotic resistance (AMR)^* which will be held on June 7^th, 2022 at PariSanté Campus – 2, rue d’Oradour-sur-Glane – Paris 15^e – France).

In 2022, strategies to fight antibiotic resistance require concerted actions across the “One Health” continuum. In this context, the symposium is organised in presentations and debates by organisations and agencies, public and private research actors and representatives of EU Member States around various challenges.

The aim is to examine the future action plans envisaged to fight antibiotic resistance in terms of research and innovation, to present new economic models linked to it, the contribution Big Data and artificial intelligence development as well as the human and social sciences.

Finally, concerning the environment, it will be a question of defining the challenges and determining the priorities.

PROGRAM

To attend the conference in-person or online, the registration is free but compulsory : https://uefranceamr.sciencesconf.org/registration

If you choose to attend the conference online, a login link to the conference platform and a password will be sent to you following your registration.

If you choosed the in-person attendance option during your registration, we will confirm you shortly if your registration is validated and if you can come on site. Indeed, the number of participants is limited on the Parisanté Campus.

If your in-person attendance cannot be validated, we will send you a login link and individual password to attend to the online conference.

^*This event is not organised by the French Government. However, it is authorised by the Government to use the emblem of the French Presidency of the Council of the European Union.

COMMITTEES

Scientific Board

• Antoine ANDREMONT (Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation (MESRI), Paris)
• Paola B. ARIMONDO (UMR 3523 Institut Pasteur/CNRS, Paris)
• Alain BOUSQUET-MELOU (RESINFIT UMR 1092 Inserm, École nationale vétérinaire de Toulouse, Toulouse)
• Catherine DUMARTIN (UMR 1219 Inserm/Université de Bordeaux, Bordeaux)
• Nicolas FORTANÉ (Institut de recherche interdisciplinaire en sciences sociales (IRISSO) UMR 7170-1427 CNRS/INRAE/Université Paris-Dauphine, Paris)
• Sophie GAY (Agence nationale de la recherche (ANR), Paris)
• Évelyne JOUVIN-MARCHE (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)
• Solen KERNÉIS (AP-HP, Hôpitaux Universitaires Paris Centre-Cochin, IAME, Inserm, Paris)
• Jean-Yves MADEC (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (Anses), Lyon)
• Marie-Cécile PLOY (RESINFIT UMR 1092 Inserm/Université de Limoges, Limoges)

Organizing Board

• Antoine ANDREMONT (Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation, Paris )
• Myriem BELKACEM (Département Information scientifique et communication (Disc), Inserm, Paris)
• Guillaume FUSAI (Département des partenariats et des relations extérieures (DPRE), Inserm, Paris)
• Paola B.ARIMONDO (UMR 3523 Institut Pasteur/CNRS, Paris)
• Évelyne JOUVIN-MARCHE (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)
• Anne-Claire LANGLOIS (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)
• Emilie NOGUEZ (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)
• Patricia RENESTO (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)
• Angelica TELLIER-TERAWAKI (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M,) Inserm, Paris)
• Tomwesso TCHANGBALARANG (Institut thématique Immunologie, inflammation, infectiologie et microbiologie (I3M), Inserm, Paris)

MORE INFORMATION